Correlation between hyperglicemia and CNS cells, focusing on the glial activity;Correlação entre hiperglicemia e células do SNC, com enfoque na atividade glial

Revista Neurociencias

Volumn 20, Issue 2, 2012, Pages 294-301

  Mello, Amanda de Souza ^a   Quincozes Santos, André ^a,b   Funchal, Cláudia ^a,b  

^a Centro Universitário Metodista Do IPA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Astrocytes; Excitotoxicity; Glutamate; Hyperglycemia; Oxidative stress

Indexed keywords

REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; BRAIN METABOLISM; CELL ACTIVITY; CELL SURVIVAL; CORRELATION ANALYSIS; DIABETES MELLITUS; EXCITOTOXICITY; GLIA CELL; HYPERGLYCEMIA; NERVOUS SYSTEM INFLAMMATION; SYSTEMATIC REVIEW;

EID: 84863970285     PISSN: 01043579     EISSN: 19844905     Source Type: Journal    
DOI: 10.34024/rnc.2012.v20.8284     Document Type: Article

References (64)

1. Grassiolli S. Contribuição da função da célula beta pancreática na manutenção da normoglicemia em ratos obesos (Tese). Maringá: UEM, 2004, 162p.
2. Praticò D. Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 2002;63:563-7. http://dx.doi.org/10.1016/S0006-2952(01)00919-4
3. Nardin P. Avaliação dos parâmetros bioquímicos e morfológicos em células gliais expostas ao um meio com alto conteúdo de glicose. (Dissertação). Porto Alegre: UFRGS, 2006, 53p.
4. Gusatti M. Modelagem matemática do acoplamento entre atividade elétrica cerebral, metabolismo e hemodinâmica. (Dissertação). Florianópolis: UFSC, 2006, 01p.
5. Jacques-Silva MC, Gemelli T, Carvalho CAS, Funchal C. Papel dos astrócitos no sistema nervoso central. Ciência em Movimento 2007;18:61-9.
6. Young JK, Garvey JS, Huang PC. Glial immunoreactivity for metallothionein in the rat brain. Glia 1991;4:602-10. http://dx.doi.org/10.1002/glia.440040607
7. Fellin T, Carmignoto G. Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. Physiology in press 2004;559:3-15.
8. Lent R. Cem bilhões de neurônios: conceitos fundamentais de neurociência. São Paulo: Atheneu, 2001, 714 p.
9. Markiewicz I, Lukomska B. The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol 2006;66:343-58.
10. Maragaskis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol 2001;58:365-70. http://dx.doi.org/10.1001/archneur.58.3.365
11. Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004;15:461-73. http://dx.doi.org/10.1016/j.nbds.2003.12.007
12. Puskas F, Grocott HP, White WD, Mathew JP, Newman M, Bar-Yosef S. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 2007;84:1467-73. http://dx.doi.org/10.1016/j.athoracsur.2007.06.023
13. Choi DW. Calcium-mediated neurotoxity: relationship to specific channel types and role in ischemic damage. Trends in Neurosci 1988A;11:465-9. http://dx.doi.org/10.1016/0166-2236(88)90200-7
14. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988B;1:623-34. http://dx.doi.org/10.1016/0896-6273(88)90162-6
15. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nature 2009;10:1-14.
16. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danbolt NC, Volterra A. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996;5976-79.
17. Emerit J. Neurodegenerative disease and oxidative stress. Biomed Pharmacother 2004;58:39-46. http://dx.doi.org/10.1016/j.biopha.2003.11.004
18. Sanz A, Caro P, Ibanez J, Gomez J, Gredilla R, Barja G. Dietary restriction at old age lowers mitochondrial oxygen radical production and leak at complex I and oxidative DNA damage in rat brain. J Bioenerg 2005;37:83-90. http://dx.doi.org/10.1007/s10863-005-4131-0
19. Kimelberg H K, Noremberg M D. Astrocytes. Scientific Am 1989;260:44-52. http://dx.doi.org/10.1038/scientificamerican0489-66
20. Rakic P. Elusive radial glial cells: historical and evolutionsary perspective. Glia 2003;43:19-32. http://dx.doi.org/10.1002/glia.10244
21. Nedeegaard M, Ranson B, Goldman SA. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci 2003;26:523-30. http://dx.doi.org/10.1016/j.tins.2003.08.008
22. Chenn A. A Top-NOTCH Way to Make Astrocytes, Dev Cell 2009;1:1-2.
23. Anderson CM, swanson RA Astrocyte glutamate transport: review of properties, regulation and physiological functions. Glia 2000;32:1-14. http://dx.doi.org/10.1002/1098-1136(200010)32:13.0.CO;2-W, http://dx.doi.org/10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.3.CO;2-N
24. Waaagepetersen HS, Sonnewald U, Schoesboe A. Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist 2003;9:398-403. http://dx.doi.org/10.1177/1073858403254006
25. Lefrançois T, Peschannski M, Tardy M. Neuritic ougrowth associated with astroglial phenotypic changers induced by antisense glial fibrillary acidic protein (GFAP) mRNA in jured neuron-astrocyte cocultures. J Neurosci 1997;17:4121-8.
26. Menet V, Ribota M G, Chauvet N, Crian M J, Colucciciguyon E, Privat A. Inactivation of the glial fibrillary acidic protein gene, but not of vimentin, improves neuronal surnical and neurite growth by modifying adhesion molecule espression. J Neurosci 2001;16:6147-58.
27. Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 1994;4:229-37. http://dx.doi.org/10.1111/j.1750-3639.1994.tb00838.x
28. Clark EJ, Allan V. Intermediate filaments: vimentin moves in. Curr Biol 2002;12:596-8. http://dx.doi.org/10.1016/S0960-9822(02)01102-8
29. Weinstein DE, Shelannski ML, Liem RK. Suppression by antisense mRNA demostrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 1991;112:1205-13. http://dx.doi.org/10.1083/jcb.112.6.1205
30. Alexanian AR, Burgurg JR. Neuronal survival activity of S100B beteba is enhacend by calcineurin inhibitors and requires activation of nf-kappab. FASEB J 1999;13:1611-20.
31. Rothermundt M, Peter M, Prehn HM, Arolt V. S100b in brain damage and neurodegeneration. Microsc Res Tech 2003;60:614-32. http://dx.doi.org/10.1002/jemt.10303
32. Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia 2008;12:198-204.
33. Li Y, Wang J, Sheng, J G, Lui L, Barger S W, Jones R A, et al. S100B Increases of b-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 1998;71:1421-8. http://dx.doi.org/10.1046/j.1471-4159.1998.71041421.x
34. Tramontina F, Tramontina AC, Souza DF, Leite MC, Gottfried C, Souza DO, et al. Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes. Cell Mol Neurobiol 2006;26:81-6.
35. Nardin P, Tortorelli L, Quincozes-Santos A, Almeida LM, Leite MC, Thomazi AP, et al. S100B Secretion in Acute Brain Slices: Modulation by Extracellular Levels of Ca(2+) and K (+). Neurochem Res 2009;15:1-2.
36. Tramontina F, Leite MC, Gonçalves D, Tramontina AC, Souza DF, Frizzo JK, et al. High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter. Neurochem Res 2006;31:815-20. http://dx.doi.org/10.1007/s11064-006-9085-z
37. Gerlach R, Demel G, Konig HG, Gross U, Raabe A, Seifert V, et al. Active secretion of s100b from astrocytes during metabolic stress. Neuroscience 2006;141:1697-701. http://dx.doi.org/10.1016/j.neuroscience.2006.05.008
38. Ozawa S, Kamyia H, Tsuzuki, K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998;54:581-618. http://dx.doi.org/10.1016/S0301-0082(97)00085-3
39. Funchal C, Rosa AM, Wajner M, Wofchuk SE, Pureur RP. Reduction of Glutamate Uptake into Cerebral Cortex of Developing Rats by the Branched-Chain Alpha-Keto Acids Accumulating in Maple Syrup Urine Disease. Neurochem Res 2004;29:747-53. http://dx.doi.org/10.1023/B:NERE.0000018846.66943.30
40. Nardin P, Tramontina F, Leite MC, Tramontina AC, Quincozes-Santos A, Almeida LMV, et al. S100B content and secretion decrease in astrocytes cultured inhigh-glucose medium, Neurochem Int 2007;50:774-82. http://dx.doi.org/10.1016/j.neuint.2007.01.013
41. Droge W. Free radicals in the physiological control of cell function Physiol Rev 2002;82:47-95.
42. Kanner BI. Glutamate transporters from brain: A novel neurotransmitter transport family. FEBS Lett 1993;325:95-9. http://dx.doi.org/10.1016/0014-5793(93)81421-U
43. Millan MH, Chapman AG, Maldrum BS. Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res 1993;14:139-48. http://dx.doi.org/10.1016/0920-1211(93)90018-3
44. Amara SG, Fontana CK. Excitatory amino acid transporters: Keeping up with glutamate. Neurochem Int 2002;41:313-8. http://dx.doi.org/10.1016/S0197-0186(02)00018-9
45. Dickie BGM. Neurotoxic and neurotrophic effects of chronic N-methyl- D-aspartate exposure upon mesencephalic dopaminergic neurons inorganotypic culture. Neuroscience 1996;72:731-41. http://dx.doi.org/10.1016/0306-4522(95)00611-7
46. Ottersen OP, Storm-Mathisen J. Glutamate. in: Björklund A, Hökfelt T, Handbook of chemical neuroanatomy. Amsterdam: Elsevier, 2000, p.18.
47. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 1999;81:163-221. http://dx.doi.org/10.1016/S0163-7258(98)00042-4
48. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-66. http://dx.doi.org/10.1002/ana.410380304
49. Dugan LL, Sensi SL, Canzoniero LMT, Handran SD, Rothman S, Lin TS, et al. Mitochondrial Production of Reactive Oxygen Species in Cortical-Neurons Following Exposure to N-Methyl-D-Aspartate. J Neurosci 1995;15:6377-88.
50. Aschner M, Syversen T, Souza DO, Rocha JB, Farina M. Involvement of glutamate and reactive oxygen species in methyl mercury neurotoxicity. Braz J Med Biol Res 2007;40:285-91. http://dx.doi.org/10.1590/S0100-879X2007000300001
51. Halliwell B, Gutteridge JM. Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Lett 1991;128:347-52. http://dx.doi.org/10.1016/0014-5793(81)80114-7
52. Halliwell B. Free radicals and antioxidants: A personal view. Nutr Rev 1994;52:253-65. http://dx.doi.org/10.1111/j.1753-4887.1994.tb01453.x
53. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. http://dx.doi.org/10.1016/j.biocel.2006.07.001
54. Halliwell B, Gutteridge JMC. Free radical in biology and medicine. 2 ed. New York: Oxford University Press; 1989, 543p.
55. Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci 2005;118:3695-703. http://dx.doi.org/10.1242/jcs.02507
56. Hoozemans JJM, Veerhuis R, Rozemuller JM, Eikelenboon P. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci 2005;24:157-65. http://dx.doi.org/10.1016/j.ijdevneu.2005.11.001
57. Balashov KE, Comabella M, Ohashi, T, Khoury, SJ, Weiner, HL Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS. Neurology 2000;55:582-3.
58. Sulzer D. Neurodegeneration and Neuroprotection in Parkinson Disease. NeuroRx: The Journal of the American Socity for Experimental NeuroTherapeutics 2004;1:139-54.
59. Lucchinetti C, Rodriguez M. Multiple sclerosis. N Engl J Med 2000;343:938-52. http://dx.doi.org/10.1056/NEJM200009283431307
60. Bjartmar C, Trapp BD. Axonal degeneration and progessive neurologic disability in ultiple sclerosis. Neurotox Res 2003;5:157-64. http://dx.doi.org/10.1007/BF03033380
61. Hickey W. Leucocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11:125-37. http://dx.doi.org/10.1006/smim.1999.0168
62. Karpus WJ, Ransohoff RM Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 1998;191:2667-71.
63. Huang D. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 2000;177:52-67. http://dx.doi.org/10.1034/j.1600-065X.2000.17709.x
64. Bacon KB, Harrison JK. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J Neuroimmunol 2000;104:92-7. http://dx.doi.org/10.1016/S0165-5728(99)00266-0